Kyowa Kirin Co (TSE:4151) Change In Receivables : 円-5,967 Mil (TTM As of Sep. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Change In Receivables?

Kyowa Kirin Co's change in receivables for the quarter that ended in Sep. 2023 was 円-2,143 Mil. It means Kyowa Kirin Co's Accounts Receivable increased by 円2,143 Mil from Jun. 2023 to Sep. 2023 .

Kyowa Kirin Co's change in receivables for the fiscal year that ended in Dec. 2022 was 円-2,704 Mil. It means Kyowa Kirin Co's Accounts Receivable increased by 円2,704 Mil from Dec. 2021 to Dec. 2022 .

Kyowa Kirin Co's Accounts Receivable for the quarter that ended in Sep. 2023 was 円113,621 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Kyowa Kirin Co's Days Sales Outstanding for the three months ended in Sep. 2023 was 97.04.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kyowa Kirin Co's liquidation value for the three months ended in Sep. 2023 was 円312,090 Mil.

Kyowa Kirin Co Change In Receivables Historical Data

The historical data trend for Kyowa Kirin Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Change In Receivables Chart

Kyowa Kirin Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-4,491.00

-642.00

-5,654.00

-5,901.00

-2,704.00

Kyowa Kirin Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Receivables	Get a 7-Day Free Trial															2,755.00	-10,864.00	11,992.00	-4,952.00	-2,143.00

Kyowa Kirin Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-5,967 Mil.

Kyowa Kirin Co (TSE:4151) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kyowa Kirin Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	113621	/	106844	*	91
=	97.04

2. In Ben Graham's calculation of liquidation value, Kyowa Kirin Co's accounts receivable are only considered to be worth 75% of book value:

Kyowa Kirin Co's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	383113	-	191908	+	0.75 * 113621	+	0.5 * 71338
=	312,090

Kyowa Kirin Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines